ESR1 and breast carcinoma: Prescribing an appropriate endocrine therapy requires finding the necessary active compounds, called ERα inhibitors, that can block the growth-increasing effect of the estrogen hormone on breast cancer cells: in effect, this can slow or even stop the cancer progression completely.